HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced yesterday that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL For Subcutaneous Use, a ...

HYDERABAD, India — Dr. Reddy's Labs announced that it has launched Sumatriptan Injection USP, Autoinjector System 6-mg/0.5-mL, a generic version of Imitrex STATdose Pen (sumatriptan succinate) ...

US group Allergan has entered into a long-term agreement with UK drug giant GlaxoSmithKline to develop and market its Botox (botulinum toxin type A) in Japan and China, and to co-promote GSK’s ...

NEW YORK Results from two clinical studies presented at this year’s American Headache Society meeting could help a needle-free migraine drug from Zogenix get Food and Drug Administration approval. The ...

IRVINE, Calif.--(BUSINESS WIRE)--Oct. 3, 2005--Allergan, Inc. (NYSE:AGN) announced today that it has entered into a long-term agreement with GlaxoSmithKline (NYSE:GSK) to develop and promote ...

RESEARCH TRIANGLE PARK, N.C., Feb. 2 (UPI) -- GlaxoSmithKline said Thursday the Food and Drug Administration approved a new formulation of its migraine treatment Imitrex injection. The approval is for ...

The injection is an auto-injector system for subcutaneous use. It is a therapeutic equivalent generic version of Imitrex Statdose Pen (sumatriptan succinate) and was launched in the US market today ...

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...

Dr Reddy’s Laboratories announced on today that it has launched Sumatriptan Injection USP, Autoinjector System 6 mg/0.5 mL, for subcutaneous use in the US market on February 25. It is a therapeutic ...